Comparison of Carvedilol to Propranolol in Reduction of Hepatic Venous Pressure Gradient in Liver Cirrhosis: A Meta‐Analysis
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16999 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Amey Joshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Sparrow Hospital-Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Carbazoles, Hepatic Veins, Hypertension, Portal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Michigan State University, Michigan State University Research Foundation.
Abstract (Originalsprache)
Background
Nonselective beta‐blockers, such as propranolol and carvedilol, are used to prevent first decompensation in patients with clinically significant portal hypertension.
Methods
We performed a systematic literature search of English language articles from inception in PubMed, Medline, and Cochrane databases to compare the effect of carvedilol and propranolol on systemic and splanchnic hemodynamics. Mean differences were pooled using a random‐effect model, and a p ‐value of < 0.05 was considered statistically significant.
Results
Seven RCTs with a total of 351 patients were involved in the final analysis. Reduction in hepatic venous pressure gradient was significantly greater in the carvedilol group (MD = −0.76, 95% CI = −1.45 to −0.08; p = 0.03). Decrease in systemic vascular resistance and mean arterial pressure was significantly greater in the carvedilol group ([MD = −190.55, 95% CI = −307.5 to −73.58; p = 0.001] and [MD = −3.65, 95% CI = −5.94 to −1.36; p = 0.002], respectively). Decrease in cardiac output was greater in the propranolol group (MD = 0.92, 95% CI = 0.45–1.38; p = 0.004). Decrease in hepatic blood flow and right atrial pressure appeared to be greater in the propranolol group; however, this did not reach statistical significance ([MD = 0.13, 95% CI = −0.06 to 0.32; p = 0.17] and [MD = 0.28, 95% CI = −0.27 to 0.83; p = 0.32], respectively). Decrease in mean pulmonary arterial pressure appeared to be greater in the carvedilol group; however, this was not statistically significant (MD = −0.75, 95% CI = −1.60 to 0.10; p = 0.08). There was no difference in incidence of rebleeding, shortness of breath, hepatic encephalopathy, and hypotension between the two groups.
Conclusion
Carvedilol demonstrated a significantly greater reduction in HVPG, SVR, and MAP compared to propranolol, with no significant difference in adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Sparrow Hospital-Michigan State University, East Lansing, Michigan, USA.
- Rawalpindi Medical University, Rawalpindi, Pakistan.
- North Bengal Medical College and Hospital, Siliguri, West Bengal, India.
- Dow University of Health Sciences, Karachi, Sindh, Pakistan.
- Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
- Department of Gastroenterology, Sparrow Hospital-University of Michigan, East Lansing, Michigan, USA.
ORCID-Profile: Amey Joshi
Förderung
- Michigan State University
- Michigan State University Research Foundation
Zitieren
APA
Joshi, A., Raja, H. A. A., Roy, P., Latif, F., Reji, R. G., Deb, N., Mui, R. K., & Shady, A. (2025). Comparison of Carvedilol to Propranolol in Reduction of Hepatic Venous Pressure Gradient in Liver Cirrhosis: A Meta‐Analysis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16999
Vancouver
Joshi A, Raja HAA, Roy P, Latif F, Reji RG, Deb N, et al. Comparison of Carvedilol to Propranolol in Reduction of Hepatic Venous Pressure Gradient in Liver Cirrhosis: A Meta‐Analysis. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16999
BibTeX
@article{Joshi2025,
author = {Joshi, Amey and Raja, Hafsa Arshad Azam and Roy, Poulami and Latif, Fakhar and Reji, Rahul George and Deb, Novonil and Mui, Ryan K and Shady, Ahmed},
title = {Comparison of Carvedilol to Propranolol in Reduction of Hepatic Venous Pressure Gradient in Liver Cirrhosis: A Meta‐Analysis},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16999}
}
EUVIMED